# Kairos Pharma (KAPA) — News

KAPA · AMEX · Stock

Canonical page: https://www.lighthorse.io/tickers/kapa/news

## Recent headlines

- [Kuros Biosciences increases 2026 annual guidance](https://www.ainvest.com/news/kuros-biosciences-increases-2026-annual-guidance-2610) — AInvest Wire, Oct 15, 2026
  Kuros Biosciences has raised its annual guidance for 2026, reflecting strong performance in the first half of 2025 and continued momentum in key markets. The company reported total medical device sales of USD 63.5 million in H1 2025, representing a 78% year-over-year increase compared to USD 35.7…
- [Pharmala Biotech Holdings Inc: Rua Bioscience and Pharmala Biotech partner to supply medicinal MDMA in New Zealand](https://www.ainvest.com/news/pharmala-biotech-holdings-rua-bioscience-pharmala-biotech-partner-supply-medicinal-mdma-zealand-2610) — AInvest Wire, Oct 8, 2026
  PharmAla Biotech Holdings Inc. (CSE: MDMA) has partnered with Rua Bioscience to supply medicinal-grade MDMA to New Zealand, marking a significant step in the company’s international expansion. The collaboration aims to support clinical research and therapeutic applications of MDMA in the region,…
- [Circuitt Brewer: Kapa (AMEX) - Volatility trading pause](https://www.ainvest.com/news/circuitt-brewer-kapa-amex-volatility-trading-pause-2610) — AInvest Wire, Oct 6, 2026
  Circuitt Brewer, a provider of financial market data and analytics, has announced a temporary pause in volatility trading for Kapa (AMEX), effective immediately. The decision follows recent market fluctuations and increased volatility in the sector, prompting the firm to reassess risk management…
- [Kairos Pharma - Modifies phase 2 protocol to enroll patients earlier in disease progression](https://www.ainvest.com/news/kairos-pharma-modifies-phase-2-protocol-enroll-patients-earlier-disease-progression-2610) — AInvest Wire, Oct 6, 2026
- [Kairos Pharma: 1-for-7 reverse stock split](https://www.ainvest.com/news/kairos-pharma-1-7-reverse-stock-split-2608) — AInvest Wire, Aug 21, 2026
  Kairos Pharma Inc. (OTC: KPHR) has announced a 1-for-7 reverse stock split, effective as of the market open on August 22, 2026. The move is intended to comply with the minimum share price requirement set by the OTC Markets Group for continued listing [1]. The company stated that the reverse stock…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).